Vaccines for preventing influenza in healthy adults
Open accessThe DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Different types of influenza vaccines are currently produced worldwide. Healthy adults are presently targeted mainly in North America. OBJECTIVES: Identify, retrieve and assess all studies evaluating the effects of vaccines against influenza in healthy adults. SEARCH STRATEGY: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library, 2010, issue 2), MEDLINE (January 1966 to June 2010) and EMBASE (1990 to June 2010). SELECTION CRITERIA: Randomised controlled trials (RCTs) or quasi-RCTs comparing influenza vaccines with placebo or no intervention in naturally-occurring influenza in healthy individuals aged 16 to 65 years. We also included comparative studies assessing serious and rare harms. DATA COLLECTION AND ANALYSIS: Two review authors independently assessed trial quality and extracted data. MAIN RESULTS: We included 50 reports. Forty (59 sub-studies) were clinical trials of over 70,000 people. Eight were comparative non-RCTs and assessed serious harms. Two were reports of harms which could not be introduced in the data analysis. In the relatively uncommon circumstance of vaccine matching the viral circulating strain and high circulation, 4% of unvaccinated people versus 1% of vaccinated people developed influenza symptoms (risk difference (RD) 3%, 95% confidence interval (CI) 2% to 5%). The corresponding figures for poor vaccine matching were 2% and 1% (RD 1, 95% CI 0% to 3%). These differences were not likely to be due to chance. Vaccination had a modest effect on time off work and had no effect on hospital admissions or complication rates. Inactivated vaccines caused local harms and an estimated 1.6 additional cases of Guillain-Barré Syndrome per million vaccinations. The harms evidence base is limited. AUTHORS' CONCLUSIONS: Influenza vaccines have a modest effect in reducing influenza symptoms and working days lost. There is no evidence that they affect complications, such as pneumonia, or transmission.WARNING: This review includes 15 out of 36 trials funded by industry (four had no funding declaration). An earlier systematic review of 274 influenza vaccine studies published up to 2007 found industry funded studies were published in more prestigious journals and cited more than other studies independently from methodological quality and size. Studies funded from public sources were significantly less likely to report conclusions favorable to the vaccines. The review showed that reliable evidence on influenza vaccines is thin but there is evidence of widespread manipulation of conclusions and spurious notoriety of the studies. The content and conclusions of this review should be interpreted in light of this finding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–223 of 223
Serres, G. D., Boulianne, N., Duval, B., Rochette, L., Grenier, J. L., Roussel, R., Donaldson, D., Tremblay, M., Toth, E., Ménard, S., et al. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00095-1 · Cited by 23
Selective uptake of influenza vaccine and pregnancy outcomes
Cantu, J., Biggio, J., Jauk, V. C., Wetta, L., Andrews, W. J., & Tita, A. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.775419 · Cited by 23
Choe, Y. J., Cho, H., Kim, S. N., Bae, G., & Lee, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.129 · Cited by 22
Kim, J.-H., Cho, H.-Y., Hennessey, K. A., Lee, H. J., Bae, G. R., & Kim, H. C. (2012) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.65.99 · Cited by 21
Preventing Influenza in Healthy Adults: The Evolving Story
Monto, A. S. (2000) · JAMA · doi:10.1001/jama.284.13.1699 · Cited by 20
Hellenbrand, W., Jorgensen, P., Schweiger, B., Falkenhorst, G., Nachtnebel, M., Greutélaers, B., Träder, C., & Wichmann, O. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-127 · Cited by 20
A CLINICAL TRIAL OF INFLUENZA VACCINE IN CANBERRA
Edmondson, K. W., Graham, D. S. M., & Warrurton, M. F. (1970) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1970.tb84667.x · Cited by 19
A controlled trial of inactivated monovalent influenza A vaccines in general practice
Mair, H. J., Sansome, D. A. W., & Tillett, H. E. (1974) · Journal of Hygiene · doi:10.1017/s0022172400024189 · Cited by 19
Kiderman, A., Furst, A., Stewart, B., Greenbaum, E., Morag, A., & Zakay‐Rones, Z. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(00)00175-x · Cited by 18
Rouleau, I., Serres, G. D., Skowronski, D. M., Drolet, J. P., Lemire, C., Toth, E., & Landry, M. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.04.059 · Cited by 17
Mastrangelo, G., Rossi, C. R., Pfahlberg, A. B., Marzia, V., Barba, A., Baldo, M. J. M., Fadda, E., Milan, G., & Kölmel, K. F. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007658503740 · Cited by 16
Could Influenza Vaccination Prevent Myocardial Infarction, Stroke and Sudden Cardiac Death?
Meyers, D. G. (2003) · American Journal of Cardiovascular Drugs · doi:10.2165/00129784-200303040-00002 · Cited by 16
Phonrat, B., Pitisuttithum, P., Chamnanchanunt, S., Puthavathana, P., Kosoltanapiwat, N., Louisirirotchanakul, S., Dhitavat, J., Thirapakpoomanunt, S., Chokevivat, V., & Wibulpolprasert, S. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.082 · Cited by 16
Phillips, C. J., Woolpert, T., Sevick, C. J., Faix, D. J., Blair, P. J., & Crum‐Cianflone, N. F. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis860 · Cited by 16
Aoki, F. Y., SITAR, D. S., Milley, E. V., Hughes, H. E., Sekla, L., Sheppard, T., Stiver, H. G., Hammond, G., Vermeersch, C., Cooper, T., et al. (1986) · Military Medicine · doi:10.1093/milmed/151.9.459 · Cited by 16
Domínguez, F., Castilla, J., Godoy, P., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.090 · Cited by 13
Nazareth, I., Silva, F. T. D., Rosillon, D., Haguinet, F., & Bauchau, V. (2013) · BMJ Open · doi:10.1136/bmjopen-2012-001912 · Cited by 13
Al-Dabbagh, M. A., Lapphra, K., Scheifele, D. W., Halperin, S. A., Langley, J. M., Cho, P., Kollmann, T. R., Li, Y., Serres, G. D., Fortuno, E. S., et al. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00659-12 · Cited by 13
Moro, M. L., Nobilio, L., Voci, C., Mario, S. D., Candela, S., & Magrini, N. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.090 · Cited by 11
Jefferson, T. (2004) · BMJ · doi:10.1136/bmj.329.7467.633 · Cited by 9
Self-citationEFFECTIVENESS OF AN INFLUENZA VACCINE USED IN POLAND IN THE 1998–1999 INFLUENZA SEASON
Banzhoff, A., Banzhoff, A., Kaniok, W., et al. (2001) · Immunological Investigations · doi:10.1081/imm-100104019 · Cited by 5
Rocchi, G., Ragona, G., Piga, C., et al. (1979) · Journal of Hygiene · doi:10.1017/s0022172400026206 · Cited by 5
Kurtal, H., Bronder, E., Klimpel, A., Andersohn, F., & Garbe, E. (2010) · Das Gesundheitswesen · doi:10.1055/s-0030-1266288 · Cited by 1
Cited by
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Osterholm, M. T., Kelley, N. S., Sommer, A., & Belongia, E. A. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70295-x · Cited by 1,789
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Antibody response to influenza vaccination in the elderly: A quantitative review
GOODWIN, K., VIBOUD, C., & SIMONSEN, L. (2006) · Vaccine · doi:10.1016/j.vaccine.2005.08.105 · Cited by 1,064
Guidelines for the management of adult lower respiratory tract infections - Full version
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03672.x · Cited by 942
Metadata
- Authors
- Jefferson, T., Di Pietrantonj, C., Rivetti, A., Bawazeer, G. A., Al-Ansary, L. A., & Ferroni, E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2010-07-07
- Volume
- 2
- Issue
- 7
- Pages
- CD001269-CD001269
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W2159880992
- Cited by
- 896
- References
- 223
- Type
- reference entry
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.